Brian Goff

2018

In 2018, Brian Goff earned a total compensation of $4.9M as Executive Vice President and Chief Commercial Officer at Alexion Pharmaceuticals, a 19% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$973,350
Salary$695,250
Stock Awards$3,096,323
Other$111,873
Total$4,876,796

Goff received $3.1M in stock awards, accounting for 63% of the total pay in 2018.

Goff also received $973.4K in non-equity incentive plan, $695.3K in salary and $111.9K in other compensation.

Rankings

In 2018, Brian Goff's compensation ranked 2,084th out of 14,244 executives tracked by ExecPay. In other words, Goff earned more than 85.4% of executives.

ClassificationRankingPercentile
All
2,084
out of 14,244
85th
Division
Manufacturing
754
out of 5,759
87th
Major group
Chemicals And Allied Products
250
out of 2,122
88th
Industry group
Drugs
199
out of 1,811
89th
Industry
Pharmaceutical Preparations
153
out of 1,385
89th
Source: SEC filing on March 26, 2019.

Goff's colleagues

We found five more compensation records of executives who worked with Brian Goff at Alexion Pharmaceuticals in 2018.

2018

Ludwig Hantson

Alexion Pharmaceuticals

Chief Executive Officer

2018

Julie O'Neill

Alexion Pharmaceuticals

Former Executive Vice President of Global Operations

2018

Paul Clancy

Alexion Pharmaceuticals

Chief Financial Officer

2018

Anne-Marie Law

Alexion Pharmaceuticals

Executive Vice President, Chief Patient and Employee Experience Officer

2018

John Orloff

Alexion Pharmaceuticals

Executive Vice President, Head of Research & Development

News

You may also like